Red light therapy devices are widely available in forms such as panels, masks, wraps, and blankets. Their marketing often claims to reduce inflammation, speed up recovery, and boost energy. However, the technology inside these devices varies greatly, and this difference determines whether the light reaches the tissue that needs it most.
For people dealing with joint pain, chronic inflammation, or slow recovery after exercise, the distinction between red light LEDs and infrared lasers is important. It can be the difference between surface-level relief and deep-tissue results.
What red light therapy does
Red light therapy is part of a broader category called photobiomodulation (PBM). This involves using red and near-infrared light to stimulate healing, relieve pain, and reduce inflammation at the cellular level. The primary target of PBM is an enzyme in the mitochondria called cytochrome c oxidase. When light hits this enzyme, it triggers a series of effects: increased production of ATP, a brief burst of reactive oxygen species, a rise in nitric oxide, and modulation of calcium levels.
For inflammation, the key is what happens next. Those signals activate transcription factors that improve cell survival, reduce oxidative stress, and lower inflammatory markers. Research has shown that PBM can modulate NF-kB pathways in normal cells while reducing inflammatory markers in already-activated inflammatory cells.
How LEDs work
LEDs, or light-emitting diodes, are the most common delivery method in consumer devices. They emit light across a broad area, making them good for surface-level coverage. This includes skin health, wound healing, and general circulation support. A typical red light LED panel emitting at 660nm can penetrate a few millimeters into the skin, reaching the epidermis and upper dermis. For skin-focused goals, LEDs are effective. They are also relatively affordable to manufacture. However, their diffuse, non-coherent light has a limit when it comes to depth of penetration. This matters when the target is a joint, a tendon, or deep muscle tissue.
How infrared lasers work
Lasers operate differently. Instead of scattering light in multiple directions, a laser emits a coherent, focused beam. Photons travel in the same direction, at the same wavelength, in phase with each other. This coherence allows laser light to penetrate significantly deeper into tissue than an LED emitting at the same wavelength. Near-infrared lasers operating at 808nm are well-studied for their interaction with mitochondria. Research found that 808nm NIR light directly enhances Complex IV activity in isolated mitochondria. This means the laser is not just reaching deeper tissue; it is triggering the biological mechanism that drives inflammation reduction at the cellular level. A separate study found that photobiomodulation therapy reversed all inflammatory parameters in experimental models, both vascular and cellular.
The key difference: depth of penetration and cellular reach
LEDs are broad and shallow. Lasers are focused and deep. For inflammation in a knee joint, a hip flexor, or a shoulder tendon, the tissue that needs treatment sits centimeters below the skin surface, beyond what most LED devices can reliably access. A comprehensive review confirmed that PBM reduces joint inflammation in both rheumatoid arthritis and osteoarthritis using near-infrared light. The review also noted that specific parameters, including wavelength, power density, and irradiation time, significantly affect outcomes.
Why the combination is more effective
LEDs and lasers are complementary technologies. LEDs provide broad surface coverage, supporting circulation, skin-level tissue repair, and a wider treatment area. Lasers deliver concentrated energy deep into joints and connective tissue, where inflammation tends to originate. A meta-analysis of 9 randomized controlled trials found that low-level laser therapy significantly improved pain and stiffness compared to placebo. The trial that used combined LLLT and LED phototherapy showed significant improvement across most outcomes, suggesting the dual approach may offer benefits that neither technology achieves alone.
What to look for in a dual-technology device
When evaluating a device, certain specifications matter. A wavelength of 660nm is the sweet spot for red light LEDs targeting surface tissue. A wavelength of 808nm is the most studied near-infrared wavelength for deep tissue and mitochondrial activation. Power density is also important. There is a biphasic dose response in PBM, where too little light has no effect and too much can be inhibitory. Optimal dosing matters. Skin-level contact is key because light intensity drops off rapidly with distance. A device that maintains direct skin contact delivers a more consistent dose than one held inches away. Laser classification is another factor. Medical-grade lasers, Class 1 or Class 3B, indicate the device is operating at clinically meaningful power levels.
The Kineon MOVE+ was designed around the dual-technology principle. Each module contains 8 × 660nm deep red LEDs and 10 × 808nm infrared lasers. These are the two wavelengths with the strongest evidence base for surface coverage and deep-tissue anti-inflammatory effects. The infrared lasers in the MOVE+ are Class 1 medical-grade, operating at 5mW per laser diode and 50mW per module. The device uses a modular, wearable design that keeps the light in direct contact with the skin. This eliminates the power loss that comes with distance-based panels. The result is a consistent, targeted dose delivered where it is needed, whether that is a knee, shoulder, elbow, or ankle.
The takeaway is that red light therapy works, but the device’s technology determines its effectiveness.
